Kabhi Khushi Kabhi Serum: Jaaved Jaaferi mocks Karan Johar for selling Dharma Productions stake to Poonawala

Karan Johar sells half of Dharma Production's stakes to Serum Institute's Adar Poonawalla

Billionaire vaccine maker Adar Poonawalla to buy most expensive house in London. Here's how much it will cost

WHO okays second malaria vaccine for children, to be mass-produced by India's Serum Institute

With Covid cases rising across India, former giant Serum Institute of India, has restarted the production of its Covid vaccine - Covishield. The CEO, Adar Poonawala said on Wednesday that six to seven million doses of Covishield will be made available in the next 90 days.

India: Covid vaccine demand to rise; 6-7 million doses to be available in 90 days | WION

Serum Institute of India to provide 20 mln Covishield vaccines worth $49.5 million to govt free of cost

The Serum Institute of India has dumped about 100 million doses of Covid vaccines after they expired. The company said that it has stopped the production due to low demand.

India dumps 100 million Covid vaccine doses; Serum Institute stops Covishield production

India: Vaccine maker SII forced to destroy 100 million doses of expired Covid vaccine

Novavax says its COVID-19 vaccine gets India authorisation for children aged 12 to 17 years

Will Covishield work against Omicron? It will be clear in 2-3 weeks, says Serum Institute’s Poonawalla

Serum Institute of India seeks regular marketing authorisation from DCGI for Covishield

PM Modi meets Covid vaccine manufacturers after India administers 1 billion doses

India allows Serum Institute to enrol 7-11 year olds in COVID-19 vaccine trial

US-based biotechnology company Novavax has tied up with the Serum Institute of India to manufacture its COVID-19 vaccine called Covavax. According to the company, the vaccine is 90% effective and safe.

Novavax ties up with Serum Institute to manufacture Covavax vaccine for India

Novavax vaccine efficacy data promising, clinical trials in India in advanced stage, says VK Paul

'I received threats', says Serum Institute CEO Adar Poonawalla

Serum Institute fixes Covishield vaccine prices: Rs 400 for govt hospitals, Rs 600 for private

Serum Institute of India refunds South Africa for undelivered COVID-19 vaccines

Nepal army receives 100,000 COVID-19 vaccine doses from India

Covishield vaccination will go on with full vigour: India

Mongolia requests for more vaccines from India

According to reports, Chinese hacking groups are targeting Indian vaccine makers Serum Institute of India (SII) and Bharat Biotech. Both SII and Bharat Biotech are involved in producing the COVID-19 vaccine.

Report: Hackers target Indian vaccine makers SII, Bharat Biotech

Nepal gets 1 million doses of COVID-19 vaccine bought from India

The World Health Organization approved the Oxford-AstraZeneca coronavirus vaccine for emergency use. WHO cleared the vaccines manufactured by the Serum Institute of India and South Korean company SK Biopharmaceuticals.

WHO grants emergency approval to AstraZeneca vaccine

serum-institute-of-india

Serum Institute Of India, News on Serum Institute Of India, stories on Serum Institute Of India, articles on Serum Institute Of India, Serum Institute Of India stories at Wion, Serum Institute Of India news, Serum Institute Of India latest news

Latest News on Serum Institute Of India | Read Breaking News on Serum Institute Of India | Wion

serum institute-of-india